GLP1R and chronic kidney disease: The order by which each drug in the CKD and T2D pillar is added depends on individual patient circumstances, such as their pretreatment UACR, eGFR, any contraindications and comorbidities, but generally RAAS inhibitors are added first followed by a SGLT2i or GLP-1 RA, and finerenone [39].